A combat veteran with PTSD is started on a medication targeting hyperarousal symptoms and nightmares. Which agent has the best evidence for reducing trauma-related nightmares via alpha-1 adrenoreceptor blockade in the prefrontal cortex and amygdala?
- A Sertraline
- B Propranolol
- C Prazosin ✓
- D Clonidine
Explanation
Prazosin, a selective alpha-1 adrenoceptor antagonist, is the best-evidenced pharmacological agent for PTSD nightmares. During REM sleep, norepinephrine release in the amygdala and prefrontal cortex is believed to mediate trauma replay; prazosin blocks these alpha-1 receptors, reducing nightmare frequency and intensity. Multiple RCTs support its efficacy specifically for sleep disturbance and nightmares in PTSD. Sertraline and paroxetine are FDA-approved for overall PTSD (first-line), but neither targets nightmares specifically. Propranolol (beta-blocker) and clonidine (alpha-2 agonist) reduce peripheral adrenergic symptoms but have weaker evidence for nightmares.
Reference: Kaplan & Sadock's Synopsis of Psychiatry, 11th ed.
High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP
Written and medically reviewed by the StethoPrep medical team.